151 related articles for article (PubMed ID: 23059781)
1. Reasonable extent of lymph node dissection in intentional segmentectomy for small-sized peripheral non-small-cell lung cancer: from the clinicopathological findings of patients who underwent lobectomy with systematic lymph node dissection.
Matsumura Y; Hishida T; Yoshida J; Aokage K; Ishii G; Nagai K
J Thorac Oncol; 2012 Nov; 7(11):1691-7. PubMed ID: 23059781
[TBL] [Abstract][Full Text] [Related]
2. Extent of Lymph Node Dissection in Patients with Small-Sized Peripheral Non-Small Cell Lung Cancer during Intentional Segmentectomy.
Maniwa T; Ohue M; Shintani Y; Okami J
Ann Thorac Cardiovasc Surg; 2023 Dec; 29(6):271-278. PubMed ID: 37100608
[TBL] [Abstract][Full Text] [Related]
3. N2 disease in T1 non-small cell lung cancer.
Defranchi SA; Cassivi SD; Nichols FC; Allen MS; Shen KR; Deschamps C; Wigle DA
Ann Thorac Surg; 2009 Sep; 88(3):924-8. PubMed ID: 19699921
[TBL] [Abstract][Full Text] [Related]
4. Segmentectomy versus lobectomy for small-sized pure solid non-small cell lung cancer.
Li Z; Xu W; Pan X; Wu W; Chen L
Thorac Cancer; 2023 Apr; 14(11):1021-1028. PubMed ID: 36882365
[TBL] [Abstract][Full Text] [Related]
5. Selective Mediastinal Lymph Node Dissection Strategy for Clinical T1N0 Invasive Lung Cancer: A Prospective, Multicenter, Clinical Trial.
Zhang Y; Deng C; Zheng Q; Qian B; Ma J; Zhang C; Jin Y; Shen X; Zang Y; Guo Y; Fu F; Li H; Zheng S; Wu H; Huang Q; Wang S; Liu Q; Ye T; Sun Y; Zhang Y; Xiang J; Hu H; Li Y; Chen H
J Thorac Oncol; 2023 Jul; 18(7):931-939. PubMed ID: 36841542
[TBL] [Abstract][Full Text] [Related]
6. Is tumor diameter a risk factor for occult N1 metastasis in patients with peripheral non-small cell lung cancer which is smaller than 3 cm?
Sayan M; Celik A; Kankoc A; Akarsu I; Aslan MT; Kurtoglu A; Ahmedova G; Tastepe AI
Updates Surg; 2023 Dec; 75(8):2335-2342. PubMed ID: 37382803
[TBL] [Abstract][Full Text] [Related]
7. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer with radiologically pure-solid appearance in Japan (JCOG0802/WJOG4607L): a post-hoc supplemental analysis of a multicentre, open-label, phase 3 trial.
Hattori A; Suzuki K; Takamochi K; Wakabayashi M; Sekino Y; Tsutani Y; Nakajima R; Aokage K; Saji H; Tsuboi M; Okada M; Asamura H; Nakamura K; Fukuda H; Watanabe SI; ;
Lancet Respir Med; 2024 Feb; 12(2):105-116. PubMed ID: 38184010
[TBL] [Abstract][Full Text] [Related]
8. [Progress in Survival Prognosis of Segmentectomy for
Early-stage Non-small Cell Lung Cancer].
Rao S; Ye L; Cui X; Sun Q; Cao R; Xiao S; Yang J; Wang W; Zhao G; Huang Y
Zhongguo Fei Ai Za Zhi; 2020 Sep; 23(9):830-836. PubMed ID: 32957171
[TBL] [Abstract][Full Text] [Related]
9. A multicenter propensity score-matched analysis of lymphadenectomy in N1-positve lung cancer.
Handa Y; Tsutani Y; Mimae T; Miyata Y; Ito H; Shimada Y; Nakayama H; Ikeda N; Okada M
Jpn J Clin Oncol; 2023 Dec; 53(12):1183-1190. PubMed ID: 37622593
[TBL] [Abstract][Full Text] [Related]
10. Importance of Lymph Node Evaluation in ≤2-cm Pure-Solid Non-Small Cell Lung Cancer.
Choi S; Yoon DW; Shin S; Kim HK; Choi YS; Kim J; Shim YM; Cho JH
Ann Thorac Surg; 2024 Mar; 117(3):586-593. PubMed ID: 36608755
[TBL] [Abstract][Full Text] [Related]
11. A Multi-Institutional, Randomized, Phase III Trial Comparing Anatomical Segmentectomy and Lobectomy for Clinical Stage IA3 Pure-Solid Non-Small-Cell Lung Cancer: West Japan Oncology Group Study WJOG16923L (STEP UP Trial).
Kamigaichi A; Hamada A; Tsuboi M; Yoshimura K; Okamoto I; Yamamoto N; Tsutani Y
Clin Lung Cancer; 2024 Jun; 25(4):384-388.e1. PubMed ID: 38360496
[TBL] [Abstract][Full Text] [Related]
12. Multiparametric evaluation of mediastinal lymph node metastases in clinical T0-T1c stage non-small-cell lung cancers.
Wang S; Bao X; Yang F; Shi H
Eur J Cardiothorac Surg; 2024 Mar; 65(3):. PubMed ID: 38429956
[TBL] [Abstract][Full Text] [Related]
13. Distinct impacts of radiological appearance on lymph node metastasis and prognosis based on solid size in clinical T1 non-small cell lung cancer.
Li Z; Pan C; Xu W; Zhao C; Pan X; Wang Z; Wu W; Chen L
Respir Res; 2024 Feb; 25(1):96. PubMed ID: 38383329
[TBL] [Abstract][Full Text] [Related]
14. Metastatic pathways to the lower zone by segment in patients with clinical T1 lower lobe non-small cell lung cancer.
Maniwa T; Ohue M; Kanzaki R; Shintani Y; Okami J
Gen Thorac Cardiovasc Surg; 2024 Mar; ():. PubMed ID: 38498143
[TBL] [Abstract][Full Text] [Related]
15. Omitting Lymph Node Dissection for Small Ground-Glass Opacity-Dominant Tumors.
Mimae T; Miyata Y; Tsubokawa N; Kudo Y; Nagashima T; Ito H; Ikeda N; Okada M
Ann Thorac Surg; 2024 Mar; ():. PubMed ID: 38513985
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of carbon ion radiotherapy compared with segmentectomy for ground glass opacity-dominant early-stage lung cancer.
Mizobuchi T; Nomoto A; Wada H; Yamamoto N; Nakajima M; Fujisawa T; Suzuki H; Yoshino I
Radiat Oncol; 2023 Dec; 18(1):201. PubMed ID: 38110971
[TBL] [Abstract][Full Text] [Related]
17. National trends in the quality of segmentectomy for lung cancer.
Logan CD; Jacobs RC; Feinglass J; Lung K; Kim S; Bharat A; Odell DD
J Thorac Cardiovasc Surg; 2023 Jan; 165(1):351-363.e20. PubMed ID: 36088143
[TBL] [Abstract][Full Text] [Related]
18. Mediastinal lymph node dissection versus spared mediastinal lymph node dissection in stage IA non-small cell lung cancer presented as ground glass nodules: study protocol of a phase III, randomised, multicentre trial (MELDSIG) in China.
Li C; Ni Y; Liu C; Liu R; Zhang C; Song Z; Liu H; Jiang T; Zhang Z
BMJ Open; 2023 Oct; 13(10):e075242. PubMed ID: 37898488
[TBL] [Abstract][Full Text] [Related]
19. Metastatic potential of T1a and T1b non-small cell lung cancer: analysis in the Czech population.
Tulinský L; Kepičová M; Mitták M; Martínek L
Rozhl Chir; 2023; 102(6):244-250. PubMed ID: 38286653
[TBL] [Abstract][Full Text] [Related]
20. The presence of intraepithelial CD45RO+ cells in resected lymph nodes with metastases from NSCLC patients is an independent predictor of disease-specific survival.
Kilvaer TK; Paulsen EE; Khanehkenari MR; Al-Saad S; Johansen RM; Al-Shibli K; Bremnes RM; Busund LT; Donnem T
Br J Cancer; 2016 May; 114(10):1145-51. PubMed ID: 27167450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
